Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
about
Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical reviewManagement of endocrine disease: Secondary osteoporosis: pathophysiology and managementThe use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentTreatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer.Antiresorptive therapy in the management of cancer treatment-induced bone loss.The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.
P2860
Q24597422-10918771-20A3-4040-BAD1-83D5D35DA84EQ26998249-375E7DC8-21BC-491D-9C24-FB33DCCE3B85Q34411758-67A2F39D-F536-4E62-9726-9DC1D875CC22Q36187103-80604BAF-F239-4A45-91E7-8033024B50E3Q38252425-4B2458F8-5670-4A5F-9C52-CE375F9D2A71Q38313112-49004D0E-E1D1-4DFB-8BCB-81951FACB6F2Q47138098-F29BE143-048A-4278-B37B-11FD2AE17295
P2860
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@en
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@nl
type
label
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@en
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@nl
prefLabel
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@en
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@nl
P2093
P2860
P1476
Osteoporosis prevention in pro ...... radiol and risedronate: N01C8.
@en
P2093
Amylou C Dueck
Ann E Kearns
Charles L Loprinzi
Donald W Northfelt
Jyotsna Fuloria
Kendrith M Rowland
Pamela J Atherton
Patrick J Flynn
Shaker R Dakhil
Todor Dentchev
P2860
P2888
P304
P356
10.1007/S00520-009-0655-X
P577
2009-05-27T00:00:00Z